Applied Genetic Technologies Corp.
Report 12-month clinical trial data for adult patients in ACHMB3 and ACHMA3 trials
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 27 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company expects to report 12-month data from the adult patients in both trials in second quarter of calendar year 2021”
What we found
Evidence strength A What the grades mean
The company announced 12-month clinical trial data for the ACHMB3 and ACHMA3 trials in June 2021, meeting the second quarter 2021 deadline.
-
A Applied Genetic Technologies Corp. 10-K filed 2021-09-23
“In June 2021, we announced 12-month data from our on-going Phase 1/2 ACHM clinical trials showing biological activity in patients with mutations in the ACHMB3 gene.” ✓ confirmed on the page
-
A Applied Genetic Technologies Corp. 10-Q filed 2021-11-09
“These data indicated biologic activity in the dose escalation portions in both the ACHMB3 and ACHMA3 trials.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- 12-month clinical trial data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Partly met”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Applied Genetic Technologies Corp.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C273636-022489 · Corrections policy